Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

COL2A1 Gene Achondrogenesis Type 2 Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

🔬 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing

🚑 Premium Home Collection: Hospital-grade, cold-chain certified phlebotomy service (8 AM – 11 PM daily).

🧑‍⚕️ Post-Test Clinical Guidance: Telephonic result interpretation by DHA-licensed genetic counsellors.

📋 Direct Insurance Billing: WhatsApp verification at +971 54 548 8731.

Test Overview & Methodology Comparison

The COL2A1 gene NGS test screens for pathogenic variants responsible for Achondrogenesis Type 2 (Langer-Saldino type), a severe autosomal dominant skeletal dysplasia affecting cartilage and bone development. This test utilizes next-generation sequencing of exonic and splice-site regions, ensuring comprehensive variant detection for clinical diagnosis, carrier screening, and family planning.

Feature Our Test (DNA Labs UAE) Closest Alternative (Standard Single-Gene Sanger)
Methodology NGS (Next-Generation Sequencing) with full exon coverage, CNV analysis & maternal cell contamination check Sanger sequencing limited to specific known mutations
Diagnostic Yield >99% for coding variants, including deep intronic splice variants ~85% if only common hotspots are tested
Turnaround Time 3–4 weeks (rush processing available) 4–6 weeks
Sample Types Whole blood (EDTA), extracted DNA, or FTA card Typically whole blood only
Pre-test Genetic Counselling Mandatory session with pedigree chart drawing included Often optional, not integrated
Price 2800 AED Varies (2200–3200 AED)

Physician Insight & Safety Protocols

“As a consultant medical geneticist, I emphasize that a positive COL2A1 pathogenic variant confirms Achondrogenesis type 2 with high specificity, but ultrasound and radiographic findings remain crucial for prenatal differentiation. A negative result does not exclude other lethal skeletal dysplasias, necessitating comprehensive imaging and multidisciplinary evaluation. Please discuss all test implications with your genetic counsellor before making critical decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

⚠️ Medication & Clinical Management Notice

Do not discontinue any prescribed medication, supplement, or prenatal vitamin without explicit instruction from your treating physician. This genetic test is for diagnostic purposes only and does not replace ongoing clinical monitoring or emergency care.

Exclusion Criteria & When to Seek Immediate Help

  • Exclusion Criteria: Active, untreated severe coagulopathy (INR >1.8, platelets <50,000/μL) that contraindicates blood draw; inadequate sample volume or leakage on FTA card; inability to provide informed consent for testing.
  • ER Red Flags (Call 998 immediately): Sudden severe shortness of breath or respiratory distress in the newborn/infant; suspected pathological fracture with limb deformity; signs of spinal cord compression (loss of limb movement, urinary retention).
  • Non-urgent Medical Contact: For abnormal ultrasound findings suggestive of lethal skeletal dysplasia, contact your maternal‑fetal medicine specialist directly. Do not rely solely on genetic test results for acute management.

Patient FAQ & Clinical Guidance

1. What is the accuracy of the COL2A1 NGS test compared to traditional methods?

NGS-based COL2A1 testing achieves over 99% diagnostic sensitivity for exonic and splice-site variants, significantly outperforming single-gene Sanger sequencing. Our laboratory uses a clinically validated NGS pipeline with deep coverage, allowing detection of mosaic variants as low as 10% allele fraction and CNVs. Combined with expert variant interpretation following ACMG guidelines, this minimizes false negatives/positives and is the DHA-recommended first-tier genetic test for suspected Achondrogenesis type 2. A pre-test genetic counselling session is mandatory to interpret ancestry-specific variants and ensure clinical correlation with the pedigree chart.

2. How long does it take to get results, and can the process be expedited for medical emergencies?

Standard turnaround time is 3–4 weeks, with a rush option delivering results in 10–12 business days for urgent prenatal decisions. After sample accession, DNA extraction, NGS library preparation, sequencing, bioinformatics analysis, and clinical report drafting occur in our Dubai-based ISO-accredited facility. For time-sensitive cases (e.g., impending delivery or second-trimester ultrasound abnormalities), our medical team can expedite processing upon receiving a referral note from the attending physician. Please WhatsApp +971 54 548 8731 to request rush handling before sample collection.

3. Does health insurance in the UAE cover this genetic test?

Many UAE insurers cover the COL2A1 NGS test when pre‑authorized with a genetic counselling referral, and we provide direct billing verification. Our team liaises with insurers including Daman, AXA, Oman Insurance, and Nextcare to obtain approval within 24 hours—simply share your policy details via WhatsApp. Self-pay patients can also utilise our 0% instalment option.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access-controlled, and processed exclusively within the UAE. Clinical test results are released only with explicit patient consent and under the supervision of DHA-licensed medical professionals. For any data privacy concerns, contact our Data Protection Officer at dpo@dnalabs.ae.

Clinical & Logistical Metadata

Test Name COL2A1 Gene Achondrogenesis Type 2 Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3–4 weeks (rush: 10–12 business days)
Sample Type / Matrix VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
Methodology Used Next-Generation Sequencing (NGS) with full exon coverage and CNV analysis
ICD-10-CM Code Q77.0 (Achondrogenesis)
LOINC Code 93400-5 (COL2A1 gene mutation analysis in Blood by Sequencing)
DHA Facility License & Laboratory Address Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians